Shanghai Kehua Bio-Engineering Co.,Ltd (002022.SZ)

CNY 6.62

(-0.75%)

EBITDA Summary of Shanghai Kehua Bio-Engineering Co.,Ltd

  • Shanghai Kehua Bio-Engineering Co.,Ltd's latest annual EBITDA in 2023 was 74.11 Million CNY , down -96.94% from previous year.
  • Shanghai Kehua Bio-Engineering Co.,Ltd's latest quarterly EBITDA in 2024 Q3 was -55.16 Million CNY , down -1323.53% from previous quarter.
  • Shanghai Kehua Bio-Engineering Co.,Ltd reported an annual EBITDA of 2.31 Billion CNY in 2022, up 38.31% from previous year.
  • Shanghai Kehua Bio-Engineering Co.,Ltd reported an annual EBITDA of 1.83 Billion CNY in 2021, up 18.31% from previous year.
  • Shanghai Kehua Bio-Engineering Co.,Ltd reported a quarterly EBITDA of -55.16 Million CNY for 2024 Q3, down -1323.53% from previous quarter.
  • Shanghai Kehua Bio-Engineering Co.,Ltd reported a quarterly EBITDA of -15.82 Million CNY for 2024 Q1, up 111.4% from previous quarter.

Annual EBITDA Chart of Shanghai Kehua Bio-Engineering Co.,Ltd (2023 - 2001)

Historical Annual EBITDA of Shanghai Kehua Bio-Engineering Co.,Ltd (2023 - 2001)

Year EBITDA EBITDA Growth
2023 74.11 Million CNY -96.94%
2022 2.31 Billion CNY 38.31%
2021 1.83 Billion CNY 18.31%
2020 1.52 Billion CNY 221.49%
2019 481.8 Million CNY 21.93%
2018 400.42 Million CNY 16.27%
2017 341.1 Million CNY 3.2%
2016 342.42 Million CNY 19.7%
2015 280.83 Million CNY -25.74%
2014 383.25 Million CNY -0.12%
2013 381.28 Million CNY 19.56%
2012 321.77 Million CNY 5.12%
2011 301.31 Million CNY 3.52%
2010 293.81 Million CNY 14.2%
2009 259.92 Million CNY 20.5%
2008 216.55 Million CNY 35.75%
2007 159.27 Million CNY 51.05%
2006 106.53 Million CNY 12.73%
2005 94.98 Million CNY 21.61%
2004 78.28 Million CNY 20.74%
2003 64.01 Million CNY 8.55%
2002 58.97 Million CNY 27.81%
2001 46.14 Million CNY 0.0%

Peer EBITDA Comparison of Shanghai Kehua Bio-Engineering Co.,Ltd

Name EBITDA EBITDA Difference
Double Medical Technology Inc. 301.61 Million CNY 75.426%
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. 252.63 Million CNY 70.663%
Lepu Medical Technology (Beijing) Co., Ltd. 2.35 Billion CNY 96.857%
Edan Instruments, Inc. 280.98 Million CNY 73.622%
Guangdong Biolight Meditech Co., Ltd. 36.24 Million CNY -104.502%
Beijing Leadman Biochemistry Co.,Ltd. 86.96 Million CNY 14.769%
Sinocare Inc. 537.12 Million CNY 86.201%
Ningbo David Medical Device Co., Ltd. 194.14 Million CNY 61.824%
Beijing Bohui Innovation Biotechnology Group Co., Ltd. 185.8 Million CNY 60.109%
Shanghai Kinetic Medical Co., Ltd 235.76 Million CNY 68.564%
Jafron Biomedical Co.,Ltd. 689.28 Million CNY 89.247%
Guangdong Transtek Medical Electronics Co., Ltd 74.37 Million CNY 0.345%
SonoScape Medical Corp. 544.91 Million CNY 86.398%
Tellgen Corporation 168.68 Million CNY 56.061%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 14.14 Billion CNY 99.476%
Zhejiang Tailin BioEngineering Co.,Ltd 37 Million CNY -100.29%
Shenzhen New Industries Biomedical Engineering Co., Ltd. 2.07 Billion CNY 96.428%
Contec Medical Systems Co.,Ltd 261.02 Million CNY 71.605%